Group One Trading, L.P. Leap Therapeutics, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.29 - $0.72 $1,421 - $3,528	-4,900 Reduced 18.75%	21,240 $7,000
Q4 2022 Feb 09, 2023	BUY	$0.42 - $9.18 $6,342 - $138,618	15,100 Added 136.78%	26,140 $11,000
Q3 2022 Nov 09, 2022	SELL	$0.92 - $9.3 $4,760 - $48,118	-5,174 Reduced 31.91%	11,040 $10,000
Q2 2022 Aug 11, 2022	SELL	$0.96 - $1.91 $23,234 - $46,227	-24,203 Reduced 59.88%	16,214 $19,000
Q1 2022 May 12, 2022	BUY	$1.6 - $3.35 $46,552 - $97,468	29,095 Added 256.98%	40,417 $71,000
Q4 2021 Feb 11, 2022	BUY	$2.08 - $3.65 $23,549 - $41,325	11,322 New	11,322 $37,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $275M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.